BRIEF-Insys Therapeutics says enrollment of first patient in phase II trial for treatment of cocaine dependence

* Insys therapeutics announces first patient enrolled in phase ii trial for the treatment of cocaine dependence using pharmaceutical cannabidiol Source text for Eikon: Further company coverage: